Determined the high dose of OCU410ST to be the maximum tolerated dose No serious adverse events have been reported Approved proceeding to Phase 2 using high and medium doses of OCU410ST MALVERN, Pa., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback